D4. Self-management plans
Patients with chronic illness who
participate in self-management have
better outcomes, including reduced
healthcare costs, than those who do
not.96 This study
included some people with COPD. In
COPD, behavioural education alone is
effective, although less effective
than integrated pulmonary
rehabilitation programs that include
an exercise component.93
In patients with COPD, most
exacerbations evolve over days
rather than hours, but even small
changes can precipitate a major
deterioration in functional status.
Psychosocial factors such as
depression, anxiety, panic or lack
of a carer have also been shown to
influence the model of care. The
traditional approach to
exacerbations of moderate to severe
COPD has been admission to hospital.
Recent work exploring the concept of
hospital-at-home has shown that many
patients can be managed at home by
appropriately qualified staff.223-225 Whether such treatment
is cost-effective remains
controversial.223-225
The concept of self-management
plans for patients with COPD is
derived from their success in asthma
management indicating doses and
medications to take for maintenance
therapy and for exacerbations.
Instructions for crises are often
also included. A systematic review
by Turnock et al226
found that the use of action plans
results in an increased ability to
recognise and react appropriately to
an exacerbation by individuals.
Unfortunately, there was no evidence
these behavioural changes alter
health-care utilisation. However,
pharmacological treatment of COPD is
generally less effective, as the
condition is, by definition,
non-reversible. Some interventions
have strong support (eg, use of
bronchodilators and systemic
glucocorticoids for exacerbations
and antibiotics if there is purulent
sputum). They might be more
effective if instituted early in an
exacerbation, thereby preventing
crisis and hospital admission. The
primary care team needs to develop
systems to identify those with more
severe COPD who might benefit from
more intensive education and
training in self-management skills.
GP involvement in review of
self-management plans (including
medications) may be undertaken in
the context of Domiciliary
Medication Management/Review (DMMR),
for which a Medicare Benefits
Schedule fee is applicable (EPC Item
900). This requires the involvement
of an accredited pharmacist and
patient consent.
The plan should be reviewed after
any exacerbation to make adjustments
as appropriate. Patients should be
encouraged to start additional
treatment at the earliest sign of an
impending exacerbation.
D4.1 Maintenance therapy
Detailed discussion of the
maintenance therapy for COPD appears
in Section O.
In general, the use of drugs in COPD
does not involve back-titration,
which is a core principle in asthma
management. The exception is when
oral glucocorticoids have been given
for an acute exacerbation.
D4.2 Exacerbations and crises
Detailed discussion of the
management of exacerbations is found
in
Section X. For mild to moderate
exacerbations, an increase in
inhaled bronchodilator therapy and
an increase in, or introduction of,
inhaled glucocorticoid therapy may
be beneficial.
For severe exacerbations there is
evidence for the use of
bronchodilators, antibiotics,
systemic glucocorticoids and
supplemental oxygen (if patients are
hypoxaemic). Selected patients may
benefit from early intervention with
these agents according to a
predetermined plan developed by a GP
or respiratory specialist. Some
patients can be instructed to start
using a "crisis medication pack"
while awaiting medical review. They
may also be instructed to contact a
particular member of the
multidisciplinary care team as part
of their overall care plan.
Controlled trials are required to
document the efficacy of
self-management plans in patients
with stable COPD, but, drawing on
the success of asthma action plans,
education of patients with COPD in
self-management is recommended. Written plans
are usually required to complement
such interventions (see examples at
http://www.lungnet.com.au/content/view/1/3/).